Supporting Women Towards Risk Reduction and Management of Gynecological and Obstetric Issues
SF-CSAPA
How to Support Women Already Followed Within the CSAPA Towards Risk Reduction and Management of Gynecological and Obstetric Issues
1 other identifier
observational
25
1 country
1
Brief Summary
The health of women who use drugs is a real public health issue where the midwife has an important role to play in the multidisciplinary support of the Center for Care, Support and Prevention in Addictology (CSAPA). The main objective is to identify the needs and expectations of the women received in terms of reducing risks and damage at the gynecological and obstetric level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 17, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 17, 2023
CompletedFirst Submitted
Initial submission to the registry
December 18, 2023
CompletedFirst Posted
Study publicly available on registry
January 8, 2024
CompletedMarch 13, 2024
December 1, 2023
2 months
December 18, 2023
March 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retrospective description of the needs and expectations of women in terms of gyneco-obstetric risk reduction
Through study completion, an average of 1 months
Eligibility Criteria
\- Adult women (≥ 18 years old) followed at the Center for Care, Support and Prevention in Addictology (CSAPA) of the University Hospitals of Strasbourg
You may not qualify if:
- Refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service d'Addictologie - CHU de Strasbourg - France
Strasbourg, 67091, France
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2023
First Posted
January 8, 2024
Study Start
July 17, 2023
Primary Completion
September 17, 2023
Study Completion
September 17, 2023
Last Updated
March 13, 2024
Record last verified: 2023-12